Technology

One design engine. Any organism.

Precision Plasmids are built from first principles rather than borrowed from nature. We screen for the genetic parts that make a construct replicate and segregate in a given organism, then assemble them into a vehicle whose copy number and inheritance or persistence are design inputs.

A large designed library is narrowed by screening to the genetic parts that work, and what the screen learns is fed back into the next design DESIGN BUILD & SCREEN PARTS THAT WORK LEARN

Anatomy

Two synthetic parts, working together.

A plasmid that replicates but cannot segregate drifts and is lost. One that segregates but cannot replicate runs out of copies. Precision Plasmids carry engineered versions of both functions, so the construct maintains itself in a dividing cell population without entering the genome. In non-dividing cells, segregation is replaced by persistence, the ability to remain stably in the cell.

  • Artificial replicon

    An origin and the initiator functions that go with it, so the construct replicates to a copy number of our choice, based on a customer’s needs, rather than whatever replication the host cell happens to trigger.

  • Artificial centromere

    Sequence that nucleates the host’s own mitotic partitioning machinery, so copies are actively distributed to both daughter cells instead of left to chance.

  • Payload

    Any size cargo from single genes to large, multi-gene clusters and pathways. Without a capsid, payload size is a design decision rather than a packaging limit.

  • Control elements

    Promoters, terminators and regulatory parts matched to the host organism and tuned to the product.

Staying outside the genome removes position effects and silencing at an integration site. Precision Plasmids give consistent expression and performance every time they are introduced into a cell. Once the design is in place, cargo gene expression is consistent and predictable.

Anatomy of a Precision Plasmid A circular plasmid with four labeled regions: an artificial replicon, an artificial centromere, a payload region and control elements. REPLICON CENTROMERE PAYLOAD CONTROL Precision Plasmid

The platform

Design, Build, Screen, Learn.

The same high-level design and workflow are used on every organism. We cast a wide net across the cellular functions we need, characterize the screening output, and keep what the screen teaches us.

The Design, Build, Screen, Learn cycle Design Build Screen Learn EACH ROUNDTEACHESTHE NEXT
  1. 01

    Design

    We build a plasmid design space from our technology design parameters, organism-specific genes, diversity libraries and computational prediction, then assemble it into a library we screen in the target cell.

  2. 02

    Build

    Combinatorial assembly turns the design space into candidate replicons, centromeres and regulatory parts, carried on screening plasmids.

  3. 03

    Screen

    Ultra-high-throughput screens measure what matters: does it replicate, at what copy number, is it inherited, and does it hold over many divisions.

  4. 04

    Learn

    Every screen pairs sequence with measured function. These pairs become a database and a model, and the next design round is informed by the ones that preceded it, chosen rather than sampled.

The founders built and ran this kind of screening cascade at Primordial Genetics and Primrose Bio, for enzyme and organism improvement. What is new is the target.

Validation path

Each organism de-risks and accelerates the next.

We develop in order of difficulty and evolutionary complexity. Microbial work moves fast and teaches us the design rules. Yeast is the first real test of a synthetic centromere. Mammalian cells are where the value is, and where we venture with the most data and experience under our belts.

01

First

E. coli

Proof of concept for the artificial replicon, plus high-copy plasmid production strains as a first product. Bacterial plasmids do not need a centromere, so this stage proves copy number and the screening engine.

02

Next

Yeast

The first test of a synthetic centromere in a eukaryote. Natural yeast centromere plasmids hold one or two copies with no way to set the number. A designed centromere makes it a parameter. Natural centromeres do not work in some yeast species. Our artificial centromeres will.

Key decision point
03

Then

Mammalian cells

Proof of concept in cultured mammalian cells. This is the milestone that opens pharma manufacturing at scale, and later, with partners, cell and gene therapy and regenerative medicine.

Head to head

Where Precision Plasmids sit against everything available today.

Every delivery vehicle currently on the market is strong in some areas and weak somewhere else. The gap we are building into is high delivery performance, tunability in copy number and stability, with simple, scalable manufacturing. Precision Plasmids™ = no trade-offs.

Comparison of gene delivery vehicles across payload, copy number per cell, stability and manufacturing complexity. Each value carries a rating: optimal and adjustable, intermediate effectiveness, or not optimal with limited flexibility.
TypePayloadCopy number per cellStabilityManufacturing complexityNotes and drawbacks
Naked DNAPlasmid DNA100 kb and aboveLow to high, 10 to 1000+TransientLowA low share of targeted cells receive the DNA.
Naked DNAPCR DNALow to medium, up to 10 kbLow to high, 10 to 1000+TransientLowA low share of targeted cells receive the DNA.
VirusesTransient: AAV, adenovirus, HSVLow to high, 4.5 to 100+ kbLow to medium, 0.5 to 100+TransientHighImmunogenicity, toxicity and adverse effects.
VirusesIntegrating: lentiviruses, retrovirusesLow to medium, 8 to 10 kbLow, 1 to 5StableHighInsertional oncogenesis risk, and prone to epigenetic silencing.
Autonomously replicating plasmidsStelli Bio Precision Plasmids™100 kb and aboveTunableTunableLowPotentially the best of all worlds.
Optimal and adjustableIntermediate effectivenessNot optimal, limited flexibilityCopy number per cell depends on dose and delivery method.

Precision Plasmid values are engineering design specifications, not measured data. Each is validated in turn. Precision Plasmids™ are being developed in bacteria, then yeast, then mammalian cells.

White space

Nobody combines tunable copy number and stability with deliverability. Yet.

Plot the field on two axes and the pattern is clear. Technologies that persist without integrating are too large to deliver or manufacture. Technologies that are easy to deliver and make do not persist. Viruses are immunogenic and cause adverse effects.

The upper right quadrant is empty today, which is the reason the company exists.

Select a point to read the detail.

Delivery and manufacturing versus non-integrating persistence A scatter plot. The horizontal axis is deliverable and manufacturable at plasmid scale. The vertical axis is non-integrating persistence. Artificial chromosomes sit high and left. Naked DNA and AAV sit low and right. Integrating vectors sit low and center. Precision Plasmids are the only point in the upper right. OPEN WHITE SPACE DELIVERABLE AND MANUFACTURABLE → NON-INTEGRATING PERSISTENCE → Artificial chromosomes HAC and MAC Episomal vectors S/MAR and similar Integrating vectors Lentivirus, transposons AAV and engineered capsids Naked DNA Precision Plasmids

The data layer

The screen is the dataset.

Our screens are built to generate something that does not exist in the literature: sequence paired with measured replication efficiency, copy number and mitotic stability across large designed libraries, including the constructs that fail.

Enrich the design space

Genomic and protein language models propose candidate origins, initiator proteins and centromere-nucleating sequences that a homology search alone would never surface. The library starts enriched rather than naive.

Learn sequence to function

Every screen produces labeled pairs. Those pairs train models that predict function from sequence, so the next design round is chosen rather than sampled. Negatives are captured too, which is the half of the data no publication contains.

Transfer forward

One screening architecture means every organism produces data in the same representation. Learning from bacteria and yeast carries into mammalian design, which is exactly where the technical risk concentrates.

Said plainly: AI does not make the biology work. The screens do. What AI changes is the number of design cycles needed to get there, and what happens to the data afterwards. A screen without a model is a hit list that expires. A screen with a model is a design capability that appreciates.

This section describes the data layer we are building, not assets in place today.

Tell us what it has to do.

The most useful thing a partner can bring us is a real constraint. Organism, payload size, target copy number, generations of stability.